BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoang LN, Aneja A, Conlon N, Delair DF, Middha S, Benayed R, Hensley ML, Park KJ, Hollmann TJ, Hameed MR, Antonescu CR, Soslow RA, Chiang S. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma. Am J Surg Pathol 2017;41:12-24. [PMID: 27631520 DOI: 10.1097/PAS.0000000000000721] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 16.8] [Reference Citation Analysis]
Number Citing Articles
1 Cordier F, Van der Meulen J, Loontiens S, Van Roy N, Lapeire L, Willaert W, Ferdinande L, Van de Vijver K, Van Dorpe J, Creytens D. ‘High-grade endometrial stromal sarcoma-like’ sarcoma in male: does it exist? A case report and review of the literature.’. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154228] [Reference Citation Analysis]
2 Nucci MR, Webster F, Croce S, George S, Howitt BE, Ip PP, Lee C, Rabban JT, Soslow RA, van der Griend R, Lax SF, Mccluggage WG. Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal of Gynecological Pathology 2022;41:S44-S63. [DOI: 10.1097/pgp.0000000000000911] [Reference Citation Analysis]
3 Cidre-Aranaz F, Watson S, Amatruda JF, Nakamura T, Delattre O, de Alava E, Dirksen U, Grünewald TGP. Small round cell sarcomas. Nat Rev Dis Primers 2022;8:66. [PMID: 36202860 DOI: 10.1038/s41572-022-00393-3] [Reference Citation Analysis]
4 Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group. Gynecol Oncol 2022:S0090-8258(22)00515-7. [PMID: 36114030 DOI: 10.1016/j.ygyno.2022.07.031] [Reference Citation Analysis]
5 Lee Y, Lee C. Undifferentiated Endometrial Carcinoma—Diagnostic and Therapeutic Challenges. AJSP: Reviews and Reports 2022;27:208-211. [DOI: 10.1097/pcr.0000000000000525] [Reference Citation Analysis]
6 Whittle SB, Fetzko S, Roy A, Venkatramani R. Soft Tissue and Visceral Organ Sarcomas With BCOR Alterations. J Pediatr Hematol Oncol 2022. [PMID: 35537005 DOI: 10.1097/MPH.0000000000002480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Alkanat NE, Uner A, Usubutun A. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis. Int J Surg Pathol 2022;:10668969221098087. [PMID: 35506912 DOI: 10.1177/10668969221098087] [Reference Citation Analysis]
8 Kommoss FKF, Chiang S, Köbel M, Koelsche C, Chang KT, Irving JA, Dickson B, Thiryayi S, Rouzbahman M, Rasty G, von Deimling A, Lee CH, Turashvili G. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications. Am J Surg Pathol 2022. [PMID: 35499168 DOI: 10.1097/PAS.0000000000001909] [Reference Citation Analysis]
9 Kertowidjojo EC, Bennett JA. Update on Uterine Mesenchymal Neoplasms. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.02.008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Yamaguchi K. Personalized Treatment in Uterine Sarcoma. Personalization in Gynecologic Oncology 2022. [DOI: 10.1007/978-981-19-4711-7_4] [Reference Citation Analysis]
11 Niu S, Zheng W. Endometrial stromal tumors: Diagnostic updates and challenges. Seminars in Diagnostic Pathology 2022. [DOI: 10.1053/j.semdp.2022.01.004] [Reference Citation Analysis]
12 Chapel DB, Nucci MR. An update in pathologic diagnosis of uterine mesenchymal tumours. Diagnostic Histopathology 2021;27:506-518. [DOI: 10.1016/j.mpdhp.2021.09.005] [Reference Citation Analysis]
13 Li C, Wang C. LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies. J Zhejiang Univ Sci B 2021;22:633-46. [PMID: 34414699 DOI: 10.1631/jzus.B2000797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Akaev I, Yeoh CC, Rahimi S. Update on Endometrial Stromal Tumours of the Uterus. Diagnostics (Basel) 2021;11:429. [PMID: 33802452 DOI: 10.3390/diagnostics11030429] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
15 Barets D, Appay R, Heinisch M, Battistella M, Bouvier C, Chotard G, Le Loarer F, Macagno N, Perbet R, Pissaloux D, Rousseau A, Tauziède-Espariat A, Varlet P, Vasiljevic A, Colin C, Fina F, Figarella-Branger D. Specific and Sensitive Diagnosis of BCOR-ITD in Various Cancers by Digital PCR. Front Oncol 2021;11:645512. [PMID: 33718245 DOI: 10.3389/fonc.2021.645512] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Euscher ED, Buza N, Hui P. Immunohistochemistry. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_15] [Reference Citation Analysis]
17 Micci F, Heim S, Panagopoulos I. Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma. Genes Chromosomes Cancer 2021;60:160-7. [PMID: 33099834 DOI: 10.1002/gcc.22907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
18 Momeni-Boroujeni A, Mohammad N, Wolber R, Yip S, Köbel M, Dickson BC, Hensley ML, Leitao MM Jr, Antonescu CR, Benayed R, Ladanyi M, Lee CH, Chiang S. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma. Mod Pathol 2021;34:1008-16. [PMID: 33077922 DOI: 10.1038/s41379-020-00705-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
19 Chang B, Bai Q, Liang L, Ge H, Yao Q. Recurrent uterine tumors resembling ovarian sex-cord tumors with the growth regulation by estrogen in breast cancer 1-nuclear receptor coactivator 2 fusion gene: a case report and literature review. Diagn Pathol. 2020;15:110. [PMID: 32921307 DOI: 10.1186/s13000-020-01025-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
20 Boyle W, Williams A, Sundar S, Yap J, Taniere P, Rehal P, Ganesan R. TMP3-NTRK1 rearranged uterine sarcoma: A case report. Case Rep Womens Health 2020;28:e00246. [PMID: 32939344 DOI: 10.1016/j.crwh.2020.e00246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Alabiad MA, Harb OA, Abdelfattah MT, El-shafaay BS, El-taher AK, El-hendawy EI. The values of Transgelin, Stathmin, BCOR and Cyclin-D1 expression in differentiation between Uterine Leiomyosarcoma (ULMS) and Endometrial Stromal Sarcoma (ESS); diagnostic and prognostic implications. Surg Exp Pathol 2020;3. [DOI: 10.1186/s42047-020-00065-0] [Reference Citation Analysis]
22 Subbaraya S, Murthy SS, Devi G S. Immunohistochemical and Molecular Characterization of Endometrial Stromal Sarcomas. Clin Pathol 2020;13:2632010X20916736. [PMID: 32524088 DOI: 10.1177/2632010X20916736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Hirsch MS, Watkins J. A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls. Adv Anat Pathol 2020;27:164-92. [PMID: 31149908 DOI: 10.1097/PAP.0000000000000238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
24 Kommoss FK, Chang KT, Stichel D, Banito A, Jones DT, Heilig CE, Fröhling S, Sahm F, Stenzinger A, Hartmann W, Mechtersheimer G, Sinn HP, Schmidt D, Kommoss F, von Deimling A, Koelsche C. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications. J Pathol Clin Res 2020;6:178-84. [PMID: 32352245 DOI: 10.1002/cjp2.165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
25 Hensley ML, Chavan SS, Solit DB, Murali R, Soslow R, Chiang S, Jungbluth AA, Bandlamudi C, Srinivasan P, Tap WD, Rosenbaum E, Taylor BS, Donoghue MTA, Hyman DM. Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing. Clin Cancer Res 2020;26:3881-8. [PMID: 32299819 DOI: 10.1158/1078-0432.CCR-19-3959] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
26 Chiang S, Samore W, Zhang L, Sung YS, Turashvili G, Murali R, Soslow RA, Hensley ML, Swanson D, Dickson BC, Stewart CJR, Oliva E, Antonescu CR. PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features. Am J Surg Pathol 2019;43:810-8. [PMID: 30829727 DOI: 10.1097/PAS.0000000000001239] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
27 Cotzia P, Benayed R, Mullaney K, Oliva E, Felix A, Ferreira J, Soslow RA, Antonescu CR, Ladanyi M, Chiang S. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas. Am J Surg Pathol 2019;43:662-9. [PMID: 30789359 DOI: 10.1097/PAS.0000000000001215] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 22.5] [Reference Citation Analysis]
28 Ondič O, Bednářová B, Ptáková N, Hájková V, Šteiner P, Šidlová H, Presl J, Bouda J, Alaghehbandan R, Michal M. ZC3H7B-BCOR high-grade endometrial stromal sarcoma may present as myoma nascens with cytoplasmic signet ring cell change. Virchows Arch 2020;476:615-9. [PMID: 31938824 DOI: 10.1007/s00428-020-02744-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
29 Arias-Stella JA 3rd, Benayed R, Oliva E, Young RH, Hoang LN, Lee CH, Jungbluth AA, Frosina D, Soslow RA, Antonescu CR, Ladanyi M, Chiang S. Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors. Am J Surg Pathol 2019;43:382-8. [PMID: 30489320 DOI: 10.1097/PAS.0000000000001196] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 16.5] [Reference Citation Analysis]
30 Parra-herran C. Mesenchymal and Miscellaneous Lesions of the Uterus. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00011-4] [Reference Citation Analysis]
31 Dillon JL, Tafe LJ. Gynecologic Malignancies. Genomic Medicine 2020. [DOI: 10.1007/978-3-030-22922-1_10] [Reference Citation Analysis]
32 Kommoss FKF, Stichel D, Schrimpf D, Kriegsmann M, Tessier-Cloutier B, Talhouk A, McAlpine JN, Chang KTE, Sturm D, Pfister SM, Romero-Pérez L, Kirchner T, Grünewald TGP, Buslei R, Sinn HP, Mechtersheimer G, Schirmacher P, Schmidt D, Lehr HA, Sahm F, Huntsman DG, Gilks CB, Kommoss F, von Deimling A, Koelsche C. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics. J Cancer Res Clin Oncol 2020;146:97-104. [PMID: 31768620 DOI: 10.1007/s00432-019-03093-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
33 Lax SF. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects]. Pathologe 2019;40:36-45. [PMID: 30694356 DOI: 10.1007/s00292-019-0567-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
34 Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma. Am J Surg Pathol 2018;42:791-8. [PMID: 29553955 DOI: 10.1097/PAS.0000000000001055] [Cited by in Crossref: 132] [Cited by in F6Publishing: 138] [Article Influence: 44.0] [Reference Citation Analysis]
35 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. Cham: Springer International Publishing; 2019. pp. 535-647. [DOI: 10.1007/978-3-319-46334-6_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
36 Astolfi A, Fiore M, Melchionda F, Indio V, Bertuccio SN, Pession A. BCOR involvement in cancer. Epigenomics 2019;11:835-55. [PMID: 31150281 DOI: 10.2217/epi-2018-0195] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 25.3] [Reference Citation Analysis]
37 Lax SF. ♀ Mesenchymal Tumors of the Female Genital Tract. Gynecologic and Urologic Pathology 2019. [DOI: 10.1017/9781316756423.021] [Reference Citation Analysis]
38 Zhang YY, Li Y, Qin M, Cai Y, Jin Y, Pan LY. High-grade endometrial stromal sarcoma: a retrospective study of factors influencing prognosis. Cancer Manag Res. 2019;11:831-837. [PMID: 30697075 DOI: 10.2147/cmar.s187849] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
39 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_31] [Reference Citation Analysis]
40 Howitt BE, Nucci MR. Uterine Mesenchymal Lesions. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_1] [Reference Citation Analysis]
41 Fadare O, Roma AA. Mesenchymal and Miscellaneous Neoplasms of the Uterine Corpus. Atlas of Anatomic Pathology 2019. [DOI: 10.1007/978-3-030-17931-1_5] [Reference Citation Analysis]
42 Murdock TA, Veras EFT, Kurman RJ, Mazur MT. Mesenchymal Tumors and Other Rare Neoplasms. Diagnosis of Endometrial Biopsies and Curettings 2019. [DOI: 10.1007/978-3-319-98608-1_11] [Reference Citation Analysis]
43 Tuyaerts S, Amant F. Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy. Vaccines (Basel) 2018;6:E56. [PMID: 30149610 DOI: 10.3390/vaccines6030056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
44 Tsuyoshi H, Yoshida Y. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma. Cancer Sci 2018;109:1743-52. [PMID: 29660202 DOI: 10.1111/cas.13613] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
45 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
46 Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA 3rd, Oliva E, Young RH, Hensley ML, Leitao MM Jr, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod Pathol 2018;31:674-84. [PMID: 29192652 DOI: 10.1038/modpathol.2017.162] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 19.4] [Reference Citation Analysis]
47 Busca A, Parra-Herran C. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis. Adv Anat Pathol 2017;24:354-61. [PMID: 28787279 DOI: 10.1097/PAP.0000000000000164] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
48 Micci F, Brunetti M, Dal Cin P, Nucci MR, Gorunova L, Heim S, Panagopoulos I. Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma. Genes Chromosomes Cancer 2017;56:841-5. [PMID: 28758277 DOI: 10.1002/gcc.22485] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
49 Vroobel KM, Karawita TS, Wilkinson N. New developments in endometrial stromal sarcoma. Diagnostic Histopathology 2017;23:311-22. [DOI: 10.1016/j.mpdhp.2017.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
50 Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA 3rd, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol 2017;30:1251-61. [PMID: 28621321 DOI: 10.1038/modpathol.2017.42] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 17.6] [Reference Citation Analysis]
51 Hemming ML, Wagner AJ, Nucci MR, Chiang S, Wang L, Hensley ML, George S. YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy. Gynecol Oncol 2017;145:531-5. [PMID: 28390819 DOI: 10.1016/j.ygyno.2017.03.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]